![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Hydrochloride, Tocainide
2. Tocainide
3. Tocainide Monohdyrochloride, (r)-isomer
4. Tocainide Monohydrobromide, (r)-isomer
5. Tocainide Monohydrochloride
6. Tocainide Monohydrochloride, (+-)-isomer
7. Tocainide Monohydrochloride, (s)-isomer
8. Tocainide, (+-)-isomer
9. Tocainide, (r)-isomer
10. Tocainide, (s)-isomer
11. Tonocard
12. W 36095
13. W-36095
14. W36095
15. Xylotocan
1. 71395-14-7
2. Tocainide Hcl
3. 35891-93-1
4. Tonocard
5. Tocainide Monohydrochloride
6. 2-amino-n-(2,6-dimethylphenyl)propanamide;hydrochloride
7. 2-amino-n-(2,6-dimethylphenyl)propanamide Hydrochloride
8. Tocainide Hydrochloride [usp]
9. 2k7i38ckn5
10. Tocainide (hydrochloride)
11. Propanamide, 2-amino-n-(2,6-dimethylphenyl)-, Monohydrochloride
12. Dsstox_cid_25540
13. Dsstox_rid_80942
14. Dsstox_gsid_45540
15. Tocainide Hydrochloride (usp)
16. Taquidil
17. Xylotocan
18. Cas-35891-93-1
19. Tocainide-hydrochloride
20. Unii-2k7i38ckn5
21. Tonocard (tn)
22. Einecs 275-361-2
23. 2-amino-n-(2,6-dimethylphenyl)propanamide Monohydrochloride
24. Ncgc00017005-01
25. 2-amino-2',6'-propionoxylidide Hydrochloride
26. Schembl122779
27. Tocainide Hydrochloride- Bio-x
28. Chembl1200773
29. Dtxsid5045540
30. Hy-b1798a
31. Hms1571m15
32. Tocainide (+-)-form Hydrochloride
33. Tox21_110732
34. Tox21_500344
35. Tox21_110732_1
36. Ccg-213604
37. Lp00344
38. Tocainide Hydrochloride [mart.]
39. Tocainide Hydrochloride [vandf]
40. Tocainide Hydrochloride [who-dd]
41. Ncgc00162129-06
42. Ncgc00261029-01
43. Bt164480
44. Tocainide (+/-)-form Hydrochloride
45. Cs-0013838
46. Tocainide Hydrochloride [orange Book]
47. Tocainide Hydrochloride [usp Impurity]
48. D02088
49. 6-bromo-4-quinazolinecarboxylic Acidammonium Salt
50. Tocainide Hydrochloride, >=98% (hplc), Solid
51. Sr-01000763682
52. Tocainide (+/-)-form Hydrochloride [mi]
53. Sr-01000763682-3
54. Q27254865
55. (1)-2-amino-n-(2,6-dimethylphenyl)propionamide Hydrochloride
56. Propanamide, 2-amino-n-(2,6-dimethylphenyl)-, Monohydrochloride, (+-)-
57. Tocainide Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 228.72 g/mol |
---|---|
Molecular Formula | C11H17ClN2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 228.1029409 g/mol |
Monoisotopic Mass | 228.1029409 g/mol |
Topological Polar Surface Area | 55.1 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 196 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)